Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer von Van Cutsem, Eric, Hidalgo, Manuel, Canon, Jean‐Luc, Macarulla, Teresa, Bazin, Igor, Poddubskaya, Elena, Manojlovic, Nebojsa, Radenkovic, Dejan, Verslype, Chris, Raymond, Eric, Cubillo, Antonio, Schueler, Armin, Zhao, Charles, Hammel, Pascal

Volltext

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previou... von DOUILLARD, Jean-Yves, SIENA, Salvatore, RIVERA, Fernando, KOCAKOVA, Ilona, RUFF, Paul, BLASINSKA-MORAWIEC, Maria, SMAKAL, Martin, CANON, Jean-Luc, ROTHER, Mark, OLINER, Kelly S, WOLF, Michael, GANSERT, Jennifer, CASSIDY, James, TABERNERO, Josep, BURKES, Ronald, BARUGEL, Mario, HUMBLET, Yves, BODOKY, György, CUNNINGHAM, David, JASSEM, Jacek

Volltext

Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer von VAN CUTSEM, Eric, PEETERS, Marc, WOLF, Michael, AMADO, Rafael G, SIENA, Salvatore, HUMBLET, Yves, HENDLISZ, Alain, NEYNS, Bart, CANON, Jean-Luc, VAN LAETHEM, Jean-Luc, MAUREL, Joan, RICHARDSON, Gary

Volltext

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications von Jézéquel, Pascal, Kerdraon, Olivier, Hondermarck, Hubert, Guérin-Charbonnel, Catherine, Lasla, Hamza, Gouraud, Wilfried, Canon, Jean-Luc, Gombos, Andrea, Dalenc, Florence, Delaloge, Suzette, Lemonnier, Jérôme, Loussouarn, Delphine, Verrièle, Véronique, Campone, Mario

Volltext

Trastuzumab for Patients With Axillary-Node–Positive Breast Cancer: Results of the FNCLCC-PACS 04 Trial von Spielmann, Marc, Roché, Henri, Delozier, Thierry, Canon, Jean-Luc, Romieu, Gilles, Bourgeois, Hugues, Extra, Jean-Marc, Serin, Daniel, Kerbrat, Pierre, Machiels, Jean-Pascal, Lortholary, Alain, Orfeuvre, Hubert, Campone, Mario, Hardy-Bessard, Anne-Claire, Coudert, Bruno, Maerevoet, Marie, Piot, Gilles, Kramar, Andrew, Martin, Anne-Laure, Penault-Llorca, Frédérique

Volltext

Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Sur... von Forget, Patrice, Machiels, Jean-Pascal, Coulie, Pierre G., Berliere, Martine, Poncelet, Alain J., Tombal, Bertrand, Stainier, Annabelle, Legrand, Catherine, Canon, Jean-Luc, Kremer, Yann, De Kock, Marc

Volltext

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial von ROCHE, Henri, FUMOLEAU, Pierre, VIENS, Patrice, MONNIER, Alain, VINDEVOGHEL, Anita, CAMPONE, Mario, GOUDIER, Marie-Josèphe, BONNETERRE, Jacques, FERRERO, Jean-Marc, MARTIN, Anne-Laure, GENEVE, Jean, ASSELAIN, Bernard, SPIELMANN, Marc, CANON, Jean-Luc, DELOZIER, Thierry, SERIN, Daniel, SYMANN, Michel, KERBRAT, Pierre, SOULIE, Patrick, EICHLER, Francoise

Volltext

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomize... von Buisseret, Laurence, Loirat, Delphine, Aftimos, Philippe, Maurer, Christian, Punie, Kevin, Debien, Véronique, Kristanto, Paulus, Eiger, Daniel, Goncalves, Anthony, Ghiringhelli, François, Taylor, Donatienne, Clatot, Florent, Van den Mooter, Tom, Ferrero, Jean-Marc, Bonnefoi, Hervé, Canon, Jean-Luc, Duhoux, Francois P., Mansi, Laura, Poncin, Renaud, Barthélémy, Philippe, Isambert, Nicolas, Denis, Zoë, Catteau, Xavier, Salgado, Roberto, Agostinetto, Elisa, de Azambuja, Evandro, Rothé, Françoise, Craciun, Ligia, Venet, David, Romano, Emanuela, Stagg, John, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Ignatiadis, Michail, Piccart-Gebhart, Martine

Volltext

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and... von Carene, Dimitri, Tran-Dien, Alicia, Lemonnier, Jérôme, Dalenc, Florence, Levy, Christelle, Pierga, Jean-Yves, Jacot, William, Canon, Jean-Luc, Richon, Catherine, Lacroix, Ludovic, Caux, Christophe, André, Fabrice, Michiels, Stefan

Volltext

Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer von Douillard, Jean-Yves, Oliner, Kelly S, Siena, Salvatore, Tabernero, Josep, Burkes, Ronald, Barugel, Mario, Humblet, Yves, Bodoky, Gyorgy, Cunningham, David, Jassem, Jacek, Rivera, Fernando, Kocákova, Ilona, Ruff, Paul, Błasińska-Morawiec, Maria, Šmakal, Martin, Canon, Jean Luc, Rother, Mark, Williams, Richard, Rong, Alan, Wiezorek, Jeffrey, Sidhu, Roger, Patterson, Scott D

Volltext

Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families von Van Marcke, Cedric, Helaers, Raphael, De Leener, Anne, Merhi, Ahmad, Schoonjans, Celine A., Ambroise, Jerome, Galant, Christine, Delree, Paul, Rothe, Francoise, Bar, Isabelle, Khoury, Elsa, Brouillard, Pascal, Canon, Jean-Luc, Vuylsteke, Peter, Machiels, Jean-Pascal, Berliere, Martine, Limaye, Nisha, Vikkula, Miikka, Duhoux, Francois P.

Volltext

Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD tr... von Giacchetti, Sylvie, Laas, Enora, Bachelot, Thomas, Lemonnier, Jérome, André, Fabrice, Cameron, David, Bliss, Judith, Chabaud, Sylvie, Hardy- Bessard, Anne-Claire, Lacroix-Triki, Magali, Canon, Jean-Luc, Debled, Marc, Campone, Mario, Cottu, Paul, Dalenc, Florence, Ballesta, Annabelle, Penault-Llorca, Frederique, Asselain, Bernard, Dumas, Elise, Reyal, Fabien, Gougis, Paul, Lévi, Francis, Hamy, Anne-Sophie

Volltext

Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Col... von GIACCHETTI, Sylvie, BJARNASON, Georg, LUC CANON, Jean, ADENIS, Antoine, LO RE, Giovanni, CARVALHO, Carlos, SCHUELLER, Johannes, ANCIAUX, Nicole, LENTZ, Marie-Ange, BARON, Benoit, GORLIA, Thierry, LEVI, Francis, GARUFI, Carlo, GENET, Dominique, IACOBELLI, Stefano, TAMPELLINI, Marco, SMAALAND, Rune, FOCAN, Christian, COUDERT, Bruno, HUMBLET, Yves

Volltext

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasi... von De Grève, Jacques, Van Meerbeeck, Jan, Vansteenkiste, Johan F, Decoster, Lore, Meert, Anne-Pascale, Vuylsteke, Peter, Focan, Christian, Canon, Jean-Luc, Humblet, Yves, Berchem, Guy, Colinet, Benoit, Galdermans, Danny, Bosquée, Lionel, Vermeij, Joanna, Dewaele, Alex, Geers, Caroline, Schallier, Denis, Teugels, Erik

Volltext

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised... von Bidard, François-Clément, Hardy-Bessard, Anne-Claire, Dalenc, Florence, Bachelot, Thomas, Pierga, Jean-Yves, de la Motte Rouge, Thibault, Sabatier, Renaud, Dubot, Coraline, Ferrero, Jean Marc, Ladoire, Sylvain, Levy, Christelle, Mouret-Reynier, Marie-Ange, Lortholary, Alain, Grenier, Julien, Chakiba, Camille, Stefani, Laetitia, Plaza, Jérôme Edouard, Clatot, Florian, Teixeira, Luis, D'Hondt, Véronique, Vegas, Hélène, Derbel, Olfa, Garnier-Tixidre, Claire, Canon, Jean-Luc, Pistilli, Barbara, André, Fabrice, Bièche, Ivan, Callens, Céline, Lemonnier, Jérôme, Delaloge, Suzette, PISTILLI, Barbara, DALENC, Florence, BACHELOT, Thomas, SABATIER, Renaud, DUBOT, Coraline, FRENEL, Jean-Sébastien, FERRERO, Jean-Marc, LADOIRE, Sylvain, LEVY, Christelle, MOURET-REYNIER, Marie-Ange, HARDY-BESSARD, Anne-Claire, LORTHOLARY, Alain, GRENIER, Julien, CHAKIBA, Camille, STEFANI, Laetitia, SOULIE, Patrick, PLAZA, Jérôme Edouard, CLATOT, Florian, TEIXEIRA, Luis, D'HONDT, Véronique, VEGAS, Hélène, DERBEL, Olfa, GARNIER TIXIDRE, Claire, CHENEAU, Caroline, PAITEL, Jean-François, BERNARD-MARTY, Chantal, SPAETH, Dominique, MOULLET, Isabelle, DEIANA, Laura, GREILSAMER, Charlotte, VENAT-BOUVET, Laurence, DELECROIX, Valérie, MELIS, Adrien, ORFEUVRE, Hubert, NGUYEN, Suzanne, LEGOUFFE, Eric, ZANNETTI, Alain, LE SCODAN, Romuald, DOHOLLOU, Nadine, DALIVOUST, Philippe, ARSENE, Olivier, MARQUES, Nathalie, PETIT, Thierry, MOLLON, Delphine, DAUBA, Jérôme, BONNIN, Nathalie, GARDNER, Miriam, MARTI, Adina, LEVACHE, Charles-Briac, LACHAIER, Emma, ACHILLE, Mihaela, VALMAR, Christophe, BOUAITA, Ryan, MEDIONI, Jacques, FOA, Cyril, DEL PIANO, Francesco, GOZY, Michel, ESCANDE, Anne, LEDUC, Nicolas, LUCAS, Brigitte, AMMARGUELLAT, Hanifa, NAJEM, Abeer, TROUBOUL, Fanny, DESCLOS, Hervé, MAYEUR, Didier, LORCHEL, Fabrice, BOUDRANT, Axelle, GISSEROT, Olivier, ALLEAUME, Corinne, DE GRAMONT, Aimery

Volltext

Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node‐Positive Breast Cancer: The 8‐Year Follo... von Coudert, Bruno, Asselain, Bernard, Campone, Mario, Spielmann, Marc, Machiels, Jean‐Pascal, Pénault‐Llorca, Frédérique, Serin, Daniel, Lévy, Christelle, Romieu, Gilles, Canon, Jean‐Luc, Orfeuvre, Hubert, Piot, Gilles, Petit, Thierry, Jerusalem, Guy, Audhuy, Bruno, Veyret, Corinne, Beauduin, Marc, Eymard, Jean‐Christophe, Martin, Anne‐Laure, Roché, Henri

Volltext

PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previ... von SCHWARTZBERG, Lee S, RIVERA, Fernando, KARTHAUS, Meinolf, FASOLA, Gianpiero, CANON, Jean-Luc, HECHT, J. Randolph, HUA YU, OLINER, Kelly S, GO, William Y

Volltext

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study von Garassino, Marina Chiara, Kim, Joo-Hang, Corral Jaime, Jesus, Powderly, John, Bidoli, Paolo, Wheatley-Price, Paul, Park, Keunchil, Wadsworth, Catherine, Dennis, Phillip A, Rizvi, Naiyer A, Paz-Ares Rodriguez, Luis, Novello, Silvia, Hiret, Sandrine, Schmid, Peter, Laack, Eckart, Califano, Raffaele, Vicente Baz, David, Berghmans, Thierry, Kim, Dong-Wan, Surmont, Veerle, Reck, Martin, Han, Ji-Youn, Holgado Martin, Esther, Chella, Antonio, Chopra, Akhil, Robinet, Gilles, Soto Parra, Hector, Thomas, Michael, Katakami, Nobuyuki, Su, Wu-Chou, Kim, Young-Chul, Lee, Jong-Seok, Saka, Hideo, Milella, Michele, Ramos Garcia, Inmaculada, Sibille, Anne, Atagi, Shinji, Spaeth-Schwalbe, Ernst, Nishio, Makoto, Imamura, Fumio, Derijcke, Sofie, Maeda, Tadashi, Zylla, Dylan, Santoro, Armando, Uy, Ma. Noemi, Lucien Geater, Sarayut, Kowalski, Dariusz, Chen, Yuh-Min, Spigel, David, Chewaskulyong, Busyamas, Garcia Gomez, Ramon, Alvarez Alvarez, Rosa, Yang, Chih-Hsin, Denis, Fabrice, Sakai, Hiroshi, Canon, Jean-Luc, Scholz, Christian, Kemmotsu, Hirotsugu, Azuma, Koichi, Feld, Ronald, Jassem, Jacek, Kubota, Kaoru, Waterhouse, David, Coudert, Bruno, Mark, Zsuzsanna, Chang, Gee-Chen, Herzmann, Christian, Chaudhry, Arvind, Giridharan, Selvaraj, Hesketh, Paul, Boccia, Ralph, Iannotti, Nichola, Haigentz, Missak, Reynolds, John, Nakagawa, Kazuhiko, Sugawara, Shunichi, Tan, Eng Huat, Takeda, Koji, Mohn-Staudner, Andrea, Panwalkar, Amit, Daniel, Davey, Kobayashi, Kunihiko, Ladrera, Guia Elena Imelda, Coupkova, Helena, Havel, Libor, Singh, Joginder, Murakami, Shuji, Anderson, Ian, Iqbal, Mussawar, Torri, Vamsee, Juhasz, Erzsebet, Koubkova, Leona, Levy, Benjamin, Page, Ray, Crinò, Lucio, Einspahr, David, Hagenstad, Christopher, Juat, Necy, Overton, Lindsay, Szalai, Zsuzsanna

Volltext

Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with... von Rivera, Fernando, Karthaus, Meinolf, Hecht, J. Randolph, Sevilla, Isabel, Forget, Frédéric, Fasola, Gianpiero, Canon, Jean-Luc, Guan, Xuesong, Demonty, Gaston, Schwartzberg, Lee S.

Volltext

Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised... von Miles, David, Cameron, David, Bondarenko, Igor, Manzyuk, Lyudmila, Alcedo, Juan Carlos, Lopez, Roberto Ivan, Im, Seock-Ah, Canon, Jean-Luc, Shparyk, Yaroslav, Yardley, Denise A, Masuda, Norikazu, Ro, Jungsil, Denduluri, Neelima, Hubeaux, Stanislas, Quah, Cheng, Bais, Carlos, O'Shaughnessy, Joyce

Volltext